002340:SZSEGEM Co., Ltd. Analysis
Data as of 2026-05-21 - not real-time
CN¥8.29
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading above its short‑term moving averages, with price comfortably above the 20‑day and 50‑day SMA and also above the 200‑day SMA, indicating a bullish trend. RSI sits in a neutral zone while MACD has turned bearish and volume is on a downtrend, suggesting short‑term downside pressure near the identified support level. High recent volatility combined with a very low beta points to price swings that are largely company‑specific rather than market‑driven, and the current price sits well below the recent resistance ceiling.
Fundamentally, revenue is expanding at a modest pace and margins remain thin, while the balance sheet is heavily leveraged with a debt‑to‑equity ratio far above one. Return on equity and assets are low, free cash flow is negative, and the dividend payout is modest with a low yield, raising concerns about cash sustainability. The PE multiple is slightly below the industry average, yet a discounted cash flow model implies a valuation far beneath the market price, leaving limited upside potential and highlighting valuation uncertainty.
Fundamentally, revenue is expanding at a modest pace and margins remain thin, while the balance sheet is heavily leveraged with a debt‑to‑equity ratio far above one. Return on equity and assets are low, free cash flow is negative, and the dividend payout is modest with a low yield, raising concerns about cash sustainability. The PE multiple is slightly below the industry average, yet a discounted cash flow model implies a valuation far beneath the market price, leaving limited upside potential and highlighting valuation uncertainty.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD histogram
- declining trading volume
- price approaching near‑term support
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- price above all major SMAs
- modest revenue growth
- high leverage and negative free cash flow
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- significant debt burden
- limited upside versus fair valuation
- sustained cash flow weakness
Key Metrics & Analysis
Financial Health
Revenue Growth5.10%
Profit Margin4.23%
P/E Ratio26.7
ROE6.97%
ROA2.86%
Debt/Equity129.69
P/B Ratio2.0
Op. Cash FlowCN¥3.4B
Free Cash FlowCN¥-9150367744
Industry P/E29.5
Technical Analysis
TrendBullish
RSI43.3
SupportCN¥8.14
ResistanceCN¥9.69
MA 20CN¥8.77
MA 50CN¥8.44
MA 200CN¥8.10
MACDBearish
VolumeDecreasing
Fear & Greed Index90.29
Valuation
Fair ValueCN¥2.02
Target PriceCN¥8.47
Upside/Downside2.20%
GradeFair
TypeBlend
Dividend Yield0.79%
Risk Assessment
Beta0.19
Volatility43.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.